After finishing the undergraduate program in Molecular Biology at Stockholm University, Mårten Österlund went on to earn his title of Doctor of Philosophy (PhD) in Molecular Biology at Uppsala University in 1986.Next, Dr. Mårten headed to the famous Pasteur Institute in Paris, France, where he spent two years doing post-doctoral studies. After this, he joined the workforce, and spent many years in various managerial positions at pharmaceutical companies such as Karo Bio and Meda. During this time, he acquired an extensive knowledge of the pharmaceutical market, gained vast experience of research and clinical development of pharmaceuticals, and took part in many successful launches of innovative products. In 2018, Dr. Mårten founded Pharma Way AB. The company is currently in the process of introducing DOT SHOT to the European and U.S. markets.